| Correlation between serum resistin level and adiposity in obese individuals K Azuma, F Katsukawa, S Oguchi, M Murata, H Yamazaki, A Shimada, ... Obesity research 11 (8), 997-1001, 2003 | 556 | 2003 |
| Fulminant type 1 diabetes: a nationwide survey in Japan A Imagawa, T Hanafusa, Y Uchigata, A Kanatsuka, E Kawasaki, ... Diabetes care 26 (8), 2345-2352, 2003 | 498 | 2003 |
| Differential Contributions of BRCA1 and BRCA2 to Early-Onset Breast Cancer M Krainer, S Silva-Arrieta, MG FitzGerald, A Shimada, C Ishioka, ... New England journal of medicine 336 (20), 1416-1422, 1997 | 314 | 1997 |
| Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial K Ueki, T Sasako, Y Okazaki, M Kato, S Okahata, H Katsuyama, ... The lancet Diabetes & endocrinology 5 (12), 951-964, 2017 | 298 | 2017 |
| Comparison of ipragliflozin and pioglitazone effects on nonalcoholic fatty liver disease in patients with type 2 diabetes: a randomized, 24-week, open-label, active-controlled … D Ito, S Shimizu, K Inoue, D Saito, M Yanagisawa, K Inukai, Y Akiyama, ... Diabetes care 40 (10), 1364-1372, 2017 | 279 | 2017 |
| Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 … A Imagawa, T Hanafusa, T Awata, H Ikegami, Y Uchigata, H Osawa, ... Diabetology international 3, 179-183, 2012 | 260 | 2012 |
| KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t (8; 21): a study of the … A Shimada, T Taki, K Tabuchi, A Tawa, K Horibe, M Tsuchida, R Hanada, ... Blood 107 (5), 1806-1809, 2006 | 241 | 2006 |
| Apparatus for deicing of trolley wires A Shimada, K Watanabe, K Nakajima US Patent 4,190,137, 1980 | 241 | 1980 |
| Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): Association between a promoter polymorphism and … E Kawasaki, T Awata, H Ikegami, T Kobayashi, T Maruyama, K Nakanishi, ... American journal of medical genetics Part A 140 (6), 586-593, 2006 | 207 | 2006 |
| Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated β-cell failure in fulminant type 1 diabetes S Tanaka, Y Nishida, K Aida, T Maruyama, A Shimada, M Suzuki, ... Diabetes 58 (10), 2285-2291, 2009 | 206 | 2009 |
| Elevated serum IP-10 levels observed in type 1 diabetes A Shimada, J Morimoto, K Kodama, R Suzuki, Y Oikawa, O Funae, ... Diabetes care 24 (3), 510-515, 2001 | 206 | 2001 |
| Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus A Imagawa, T Hanafusa, Y Uchigata, A Kanatsuka, E Kawasaki, ... Diabetologia 48, 294-300, 2005 | 196 | 2005 |
| Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus T Maruyama, S Tanaka, A Shimada, O Funae, A Kasuga, A Kanatsuka, ... The Journal of Clinical Endocrinology & Metabolism 93 (6), 2115-2121, 2008 | 185 | 2008 |
| Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations K Matsuda, A Shimada, N Yoshida, A Ogawa, A Watanabe, S Yajima, ... Blood, The Journal of the American Society of Hematology 109 (12), 5477-5480, 2007 | 179 | 2007 |
| Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes Y Motohashi, S Yamada, T Yanagawa, T Maruyama, R Suzuki, M Niino, ... The Journal of Clinical Endocrinology & Metabolism 88 (7), 3137-3140, 2003 | 174 | 2003 |
| The Transcriptional Activities of p53 and Its Homologue p51/p63: Similaritiesand Differences A Shimada, S Kato, K Enjo, M Osada, Y Ikawa, K Kohno, M Obinata, ... Cancer research 59 (12), 2781-2786, 1999 | 158 | 1999 |
| Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset Y Kawabata, H Ikegami, T Awata, A Imagawa, T Maruyama, E Kawasaki, ... Diabetologia 52, 2513-2521, 2009 | 152 | 2009 |
| Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy I Shimizu, H Makino, A Imagawa, H Iwahashi, Y Uchigata, A Kanatsuka, ... The Journal of Clinical Endocrinology & Metabolism 91 (2), 471-476, 2006 | 141 | 2006 |
| Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice Y Nitta, F Tashiro, M Tokui, A Shimada, I Takei, K Tabayashi, J Miyazaki Human gene therapy 9 (12), 1701-1707, 1998 | 138 | 1998 |
| Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes T Kawai, I Takei, Y Oguma, N Ohashi, M Tokui, S Oguchi, F Katsukawa, ... Metabolism 48 (9), 1102-1107, 1999 | 127 | 1999 |
